Holen Sie sich die Stockscreener-App
7.365
6.18%
-0.4049
Handel nachbörslich:
7.43
0.065
+0.88%
Schlusskurs vom Vortag:
$7.7699
Offen:
$7.8
24-Stunden-Volumen:
11,557
Relative Volume:
0.04
Marktkapitalisierung:
$5.31M
Einnahmen:
$7.83M
Nettoeinkommen (Verlust:
$-8.28M
KGV:
-0.4364
EPS:
-16.8761
Netto-Cashflow:
$-6.85M
1W Leistung:
-2.80%
1M Leistung:
+0.28%
6M Leistung:
+18.65%
1J Leistung:
-94.54%
1-Tages-Spanne:
$7.1501
$7.8255
1-Wochen-Bereich:
$7.1501
$7.8255
52-Wochen-Spanne:
$3.0765
$128.62
Moolec Science Sa Stock (MLEC) Company Profile
Firmenname
Moolec Science Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MLEC vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MLEC
Moolec Science Sa
|
7.307 | 5.64M | 7.83M | -8.28M | -6.85M | -16.88 |
VRTX
Vertex Pharmaceuticals Inc
|
435.92 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Moolec Science Sa Stock (MLEC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-27 | Eingeleitet | ROTH MKM | Buy |
Moolec Science Sa Aktie (MLEC) Neueste Nachrichten
MSN Money - MSN
Moolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGM - TipRanks
Moolec Science shareholders approve financials, re-elect directors and auditor - Investing.com
[6-K] Moolec Science SA Current Report (Foreign Issuer) | MLEC SEC FilingForm 6-K - Stock Titan
Moolec Science completes 2026 safflower planting campaign By Investing.com - Investing.com South Africa
MLEC Director Core Daniel Joaquin Files Initial Ownership, May 14, 2026 - Meyka
Moolec Science completes 2026 safflower planting campaign - Investing.com
Moolec Science Successfully Completes 2026 GLASO Commercial Planting Campaign in the United States - ACCESS Newswire
Safflower oil tops 60% GLA as Moolec finishes 2026 US planting push - Stock Titan
Moolec Science Swings to Profit on Subsidiary Deconsolidation in Latest Interim Results - TipRanks
Moolec Science Regains Nasdaq Compliance After Strengthening Equity Base - TipRanks
Moolec hits $11.3M equity to satisfy Nasdaq listing rules - Stock Titan
Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period - galvnews.com
Moolec Science (NASDAQ: MLEC) restores Nasdaq equity compliance - Stock Titan
TradingKey - TradingKey
MLEC stock extends its relentless rally, sees 35% boost today after change in shareholding - MSN
MLEC (Moolec) EPS beats estimates but revenue plummets 28.5% year-over-year, shares decline.IPO - newser.com
The working capital efficiency at Moolec (MLECW) | MLECW QX Earnings: Moolec Warrant Reports No Earnings DataDecline Phase - newser.com
MLEC Insider Filing: Director Core Daniel Joaquin Ownership Disclosure May 2026 - Meyka
MLECW Price History for Moolec Science Sa WT Stock - Barchart.com
MLEC SEC FilingsMoolec Science 10-K, 10-Q, 8-K Forms - Stock Titan
12 Consumer Staples Stocks Moving In Friday's Pre-Market Session - Sahm
Why Is Moolec Science Stock Up Despite Weak Market Sentiment? - Sahm
Moolec Science completes GLASO1 safflower industrialization phase By Investing.com - Investing.com Australia
Moolec Science completes GLASO1 safflower industrialization phase - Investing.com
Moolec Science Confirms Completion of First Phase of GLASO Industrialization Following Record 2025 Campaign; Advances 2026 Sowing and Expands Into Energy Applications - ACCESS Newswire
High-purity safflower oil pushes Moolec beyond pet food toward energy - Stock Titan
MLEC Insider Filing: Director Core Daniel Joaquin Reports Ordinary Shares, April 29, 2026 - Meyka
Contact | Statesman-Examiner - FinancialContent
MLEC Insider Filing: Core Daniel Joaquin Director Stake, April 22, 2026 - Meyka
Finanzdaten der Moolec Science Sa-Aktie (MLEC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):